Protocol
ADVERSE EVENTS, ONCHOCERCIASIS
This was a randomized, parallel-group, open-label clinical trial. The purpose of the study was to provide the first data on the safety and efficacy of IDA treatment of onchocerciasis relative to treatment with the comparator regimen of IVM plus ALB. All treatments were provided after pre-treatment with IVM to reduce Mf counts in the skin and eyes. The primary safety objective for the study was to compare rates and types of severe adverse events that occur within seven days after different treatments. The primary efficacy objective of the study was to compare the effect of different treatments for killing or sterilizing adult female 